Life
FDA Proposes Enhanced Oversight of Direct-to-Consumer Advertising as EU Strengthens AMR Commitment
Recent developments in the pharmaceutical sector include the FDA's proposal for greater control over direct-to-consumer ads and the EU's commitment to combat antimicrobial resistance.
editorial-staff
1 min read
Updated 3 days ago
Summary
The FDA is looking to expand its regulatory powers concerning direct-to-consumer advertising, aiming to ensure that consumers receive accurate and reliable information about medications.
Simultaneously, the European Union has pledged to intensify its efforts in the fight against antimicrobial resistance (AMR), a growing global health concern.
These initiatives reflect a broader trend in health regulation and international cooperation to address pressing health challenges.
Updates
- No subsequent updates recorded.